Refractory Endometrial Carcinoma (DBCOND0131051)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05039801	IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors	Bevacizumab Capivasertib Paclitaxel	treatment	1	recruiting
NCT04719273	Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer	Anastrozole Benzalkonium Onapristone	treatment	2	active_not_recruiting
NCT03008408	A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma	Everolimus Letrozole Ribociclib	treatment	2	active_not_recruiting